Coxsackievirus B4 myocarditis and meningoencephalitis in newborn twins

Neuropathology

Volumn 34, Issue 5, 2014, Pages 429-437

  Bissel, Stephanie J ^a   Winkler, Caitlin C ^a   Deltondo, Joseph ^b   Wang, Guoji ^a   Williams, Karl ^b   Wiley, Clayton A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b Allegheny County Medical Examiner's Office   (United States)

Author keywords

Congenital infection; Coxsackievirus; Encephalitis; Enterovirus; Myocarditis

Indexed keywords

ADRENAL MEDULLA; ADRENAL MEDULLA DISEASE; ADRENAL MEDULLITIS; ADULT; APNEA; ARTICLE; AUTOPSY; BRAIN NERVE CELL; BRAIN TISSUE; CARDIAC MUSCLE CELL; CASE REPORT; COXSACKIE VIRUS INFECTION; COXSACKIEVIRUS B4; DISEASE SEVERITY; ENDOCRINE PANCREAS; FEMALE; GESTATIONAL AGE; HEART TISSUE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LETHARGY; MENINGOENCEPHALITIS; MONOCHORIONIC DIAMNIOTIC TWINS; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEPHRITIS; NEWBORN; NEWBORN DEATH; NEWBORN SEPSIS; NONHUMAN; PANCREATITIS; PREMATURITY; RESUSCITATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEIZURE; SEQUENCE ANALYSIS; SYMPTOMATOLOGY; TISSUE DISTRIBUTION; TWINS; VIRUS DETECTION; VIRUS IDENTIFICATION; VIRUS MENINGOENCEPHALITIS; VIRUS MYOCARDITIS; YOUNG ADULT; ENTEROVIRUS B; MYOCARDITIS; PATHOLOGY;

COXSACKIEVIRUS INFECTIONS; ENTEROVIRUS B, HUMAN; HUMANS; INFANT, NEWBORN; MENINGOENCEPHALITIS; MYOCARDITIS; TWINS;

EID: 84907884654     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/neup.12121     Document Type: Article

References (44)

1. Tyler KL, Martin JB. Infectious Diseases of the Central Nervous System. Philadelphia, PA: F.A. Davis, 1993.
2. Berger JR, Chumley W, Pittman T, Given C, Nuovo G. Persistent Coxsackie B encephalitis: report of a case and review of the literature. J Neurovirol 2006; 12: 511-516.
3. Bryant PA, Tingay D, Dargaville PA, Starr M, Curtis N. Neonatal coxsackie B virus infection-a treatable disease? Eur J Pediatr 2004; 163: 223-228.
4. Callen J, Paes BA. A case report of a premature infant with coxsackie B1 meningitis. Adv Neonatal Care 2007; 7: 238-247.
5. Solomon T, Lewthwaite P, Perera D, Cardoso MJ, McMinn P, Ooi MH. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis 2010; 10: 778-790.
6. Zaoutis T, Klein JD. Enterovirus infections. Pediatr Rev 1998; 19: 183-191.
7. Centres for Disease Control (CDC). Nonpolio enterovirus and human parechovirus surveillance - United States, 2006-2008. MMWR Morb Mortal Wkly Rep 2010; 59: 1577-1580.
8. Moore M, Kaplan MH, McPhee J, Bregman DJ, Klein SW. Epidemiologic, clinical, and laboratory features of Coxsackie B1-B5 infections in the United States, 1970-79. Public Health Rep 1984; 99: 515-522.
9. Brecht M, Jyoti R, McGuire W, Chauhan M. A case of neonatal coxsackie B virus brainstem encephalitis. J Paediatr Child Health 2010; 46: 699-701.
10. Berger JR, Fee DB, Nelson P, Nuovo G. Coxsackie B meningoencephalitis in a patient with acquired immunodeficiency syndrome and a multiple sclerosis-like illness. J Neurovirol 2009; 15: 282-287.
11. David P, Baleriaux D, Bank WO etal. MRI of acute disseminated encephalomyelitis after coxsackie B infection. J Neuroradiol 1993; 20: 258-265.
12. Kamei S, Hersch SM, Kurata T, Takei Y. Coxsackie B antigen in the central nervous system of a patient with fatal acute encephalitis: immunohistochemical studies of formalin-fixed paraffin-embedded tissue. Acta Neuropathol (Berl) 1990; 80: 216-221.
13. Estes ML, Rorke LB. Liquefactive necrosis in Coxsackie B encephalitis. Arch Pathol Lab Med 1986; 110: 1090-1092.
14. Iwasaki T, Monma N, Satodate R, Kawana R, Kurata T. An immunofluorescent study of generalized Coxsackie virus B3 infection in a newborn infant. Acta Pathol Jpn 1985; 35: 741-748.
15. Berg AK, Olsson A, Korsgren O, Frisk G. Antiviral treatment of Coxsackie B virus infection in human pancreatic islets. Antiviral Res 2007; 74: 65-71.
16. Dotta F, Censini S, van Halteren AG etal. Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc Natl Acad Sci U S A 2007; 104: 5115-5120.
17. Foulis AK, Liddle CN, Farquharson MA, Richmond JA, Weir RS. The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom. Diabetologia 1986; 29: 267-274.
18. Ylipaasto P, Klingel K, Lindberg AM etal. Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet beta cells. Diabetologia 2004; 47: 225-239.
19. Burch GE, DePasquale NP, Sun SC, Mogabgab WJ, Hale AR. Endocarditis in mice infected with Coxsackie virus B4. Science 1966; 151: 447-448.
20. Hoshino T, Kawai C, Tokuda M. Experimental coxsackie B viral myocarditis in cynomolgus monkeys. Jpn Circ J 1983; 47: 59-66.
21. Lansdown AB. Pathological changes in the pancreas of mice following infection with Coxsackie B viruses. Br J Exp Pathol 1976; 57: 331-338.
22. Al-Hello H, Davydova B, Smura T etal. Phenotypic and genetic changes in coxsackievirus B5 following repeated passage in mouse pancreas in vivo. J Med Virol 2005; 75: 566-574.
23. Palacios G, Oberste MS. Enteroviruses as agents of emerging infectious diseases. J Neurovirol 2005; 11: 424-433.
24. Bissel SJ, Wang G, Ghosh M etal. Macrophages relate presynaptic and postsynaptic damage in simian immunodeficiency virus encephalitis. Am J Pathol 2002; 160: 927-941.
25. Fallert BA, Reinhart TA. Improved detection of simian immunodeficiency virus RNA by in situ hybridization in fixed tissue sections: combined effects of temperatures for tissue fixation and probe hybridization. J Virol Methods 2002; 99: 23-32.
26. Bissel SJ, Giles BM, Wang G, Olevian DC, Ross TM, Wiley CA. Acute murine H5N1 influenza A encephalitis. Brain Pathol 2012; 22: 150-158.
27. Jia CS, Liu JN, Li WB etal. The cross-reactivity of the enterovirus 71 to human brain tissue and identification of the cross-reactivity related fragments. Virol J 2010; 7: 47.
28. Patzke C, Max KE, Behlke J etal. The coxsackievirus-adenovirus receptor reveals complex homophilic and heterophilic interactions on neural cells. J Neurosci 2010; 30: 2897-2910.
29. Hotta Y, Honda T, Naito M, Kuwano R. Developmental distribution of coxsackie virus and adenovirus receptor localized in the nervous system. Brain Res Dev Brain Res 2003; 143: 1-13.
30. Brokhman I, Pomp O, Fishman L etal. Genetic modification of human embryonic stem cells with adenoviral vectors: differences of infectability between lines and correlation of infectability with expression of the coxsackie and adenovirus receptor. Stem Cells Dev 2009; 18: 447-456.
31. Xu R, Crowell RL. Expression and distribution of the receptors for coxsackievirus B3 during fetal development of the Balb/c mouse and of their brain cells in culture. Virus Res 1996; 46: 157-170.
32. Kallewaard NL, Zhang L, Chen JW, Guttenberg M, Sanchez MD, Bergelson JM. Tissue-specific deletion of the coxsackievirus and adenovirus receptor protects mice from virus-induced pancreatitis and myocarditis. Cell Host Microbe 2009; 6: 91-98.
33. Shi Y, Chen C, Lisewski U etal. Cardiac deletion of the Coxsackievirus-adenovirus receptor abolishes Coxsackievirus B3 infection and prevents myocarditis in vivo. J Am Coll Cardiol 2009; 53: 1219-1226.
34. Feuer R, Mena I, Pagarigan R, Slifka MK, Whitton JL. Cell cycle status affects coxsackievirus replication, persistence, and reactivation in vitro. J Virol 2002; 76: 4430-4440.
35. Feuer R, Mena I, Pagarigan RR, Harkins S, Hassett DE, Whitton JL. Coxsackievirus B3 and the neonatal CNS: the roles of stem cells, developing neurons, and apoptosis in infection, viral dissemination, and disease. Am J Pathol 2003; 163: 1379-1393.
36. Tabor-Godwin JM, Ruller CM, Bagalso N etal. A novel population of myeloid cells responding to coxsackievirus infection assists in the dissemination of virus within the neonatal CNS. J Neurosci 2010; 30: 8676-8691.
37. Chan LG, Parashar UD, Lye MS etal. Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. Clin Infect Dis 2000; 31: 678-683.
38. Wong KT, Munisamy B, Ong KC etal. The distribution of inflammation and virus in human enterovirus 71 encephalomyelitis suggests possible viral spread by neural pathways. J Neuropathol Exp Neurol 2008; 67: 162-169.
39. Yan JJ, Wang JR, Liu CC, Yang HB, Su IJ. An outbreak of enterovirus 71 infection in Taiwan 1998: a comprehensive pathological, virological, and molecular study on a case of fulminant encephalitis. J Clin Virol 2000; 17: 13-22.
40. Yang Y, Wang H, Gong EC etal. Neuropathology in 2 cases of fatal enterovirus type 71 infection from a recent epidemic in the People's Republic of China: a histopathologic, immunohistochemical, and reverse transcription polymerase chain reaction study. Hum Pathol 2009; 40: 1288-1295.
41. Zhang YC, Jiang SW, Gu WZ etal. Clinicopathologic features and molecular analysis of enterovirus 71 infection: report of an autopsy case from the epidemic of hand, foot and mouth disease in China. Pathol Int 2012; 62: 565-570.
42. Lafaille FG, Pessach IM, Zhang SY etal. Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells. Nature 2012; 491: 769-773.
43. Zhang SY, Jouanguy E, Ugolini S etal. TLR3 deficiency in patients with herpes simplex encephalitis. Science 2007; 317: 1522-1527.
44. Ma Y, Haynes RL, Sidman RL, Vartanian T. TLR8: an innate immune receptor in brain, neurons and axons. Cell Cycle 2007; 6: 2859-2868.